Enteral Collagen Peptide Protein Market Size, Share, Industry, Forecast and outlook (2024-2031)

Enteral Collagen Peptide Protein Market is Segmented By Form (Liquid, Powder), By Age (Adults, Pediatrics), By End-User (Hospital, Clinics, Nursing Home, Homecare Settings, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030

Photoinitiator Market is projected to reach a CAGR of 7% during the forecast period (2023-2030).

Collagen peptide-protein is an animal collagen-derived protein. Enteral collagen peptide protein is a high-nutrient supplement given to patients who cannot absorb enough nutrients orally but whose gastrointestinal function is adequate for digestion and absorption. When a patient cannot eat due to illness, swallowing issues, or surgery that may interfere with the usual feeding process, this procedure is used. Enteral pumps and enteral feeding tubes are used to deliver collagen peptides protein straight into a patient's stomach, duodenum, or jejunum.

Enteral Collagen Peptide Protein Market Dynamics

The global enteral collagen peptide protein market is being driven by an increase in the prevalence of chronic illnesses such as osteoarthritis and cardiovascular diseases and an increase in the use of collagen peptide protein in the healthcare sector. Furthermore, the growing geriatric population, combined with favorable government initiatives to encourage a healthy diet among the general public, will likely create profitable prospects for both incumbent participants and newcomers. During the forecast period, undeveloped emerging economies with high growth potential are expected to create new opportunities for worldwide market expansion. An increase in the number of malnutrition cases is expected to drive the market growth

In 2020, World Health Organization anticipated that 149 million children under the age of five were stunted (too short for their age), 45 million were wasted (too thin for their height), and 38.9 million were overweight or obese.Undernutrition is responsible for almost 45 percent of mortality among children under five. Low- and middle-income countries are the most affected. At the same time, childhood overweight and obesity rates are rising in these same countries.The global burden of malnutrition has substantial and long-term developmental, economic, social, and medical consequences for individuals and their families, communities, and countries. As malnutrition rates rise, so does the prevalence of chronic diseases, creating a high demand for enteral collagen peptide protein supplements.  Thus rise in malnutrition cases will boost the market growth

Moreover, cardiovascular diseases (CVDs) are the most common cause of death worldwide. Cardiovascular diseases claimed the lives of 17.9 million individuals worldwide in 2019, accounting for 32% of all deaths. Heart attacks and strokes were responsible for 85 percent of these deaths. Low- and middle-income nations account for about three-quarters of cardiovascular diseases mortality. (Source:World Health Organization). The global enteral collagen peptide protein market is being driven by an increase in the prevalence of chronic illnesses such as osteoarthritis and cardiovascular diseases.

Furthermore, there is an increase in the senior population and positive government attempts to encourage a healthy diet among the general public. The proportion of the world's population aged 60 and up will nearly double from 12 percent to 22 percent between 2015 and 2050.By 2023, the number of persons aged 60 and more will outweigh youngsters under five.By 2050, 80% of the world's elderly will live in low- and middle-income countries.(Source:World Health Organization). As a result of the growing aging population and growing interest in preventative healthcare, supplement adoption is on the rise, a major driver in increasing demand for enteral collagen peptide protein market.As a result, all of these factors are expected to contribute to market growth during the forecast period.

Lack of technological advancement in developing nations is likely to hamper the market growth

Extraction and processing of collagen proteins necessitate cutting-edge technology. The edible collagen extracted from porcine/bovine/fish skins is sent for filtration and ion exchange. Microfiltration technology is used in the filtration process, which allows the fluid to pass through a porous membrane. This is followed by heat sterilization, which necessitates high-temperature heat treatment, and, finally, spray drying of the product. The technologies mentioned above are not widely developed throughout the world, particularly in developing countries such as India, China, and the rest of Asia Pacific. As a result, collagen peptides and gelatin production is largely limited to a few countries, including the United States, the United Kingdom, and Germany.

COVID-19 Impact Analysis

The World Health Organization declared the COVID-19 to upsurge a public health emergency of worldwide significance on January 30, 2020. Around 210 countries have been affected by COVID-19. The COVID-19 pandemic is a global public health emergency that is expected to negatively influence the enteral collagen peptide protein industry, owing to a drop in meat consumption, particularly of marine and bovine products, around the world. Because fish and beef wastes are key raw materials for collagen products, this issue has directly impacted collagen peptide manufacturing. Furthermore, the COVID-19 epidemic has harmed corporate alliances and partnership chances for enteral collagen peptide protein, resulting in a decrease in enteral collagen peptide protein production. As a result of the current health crisis, the enteral collagen peptide protein market has suffered.

Enteral Collagen Peptide Protein Market Segment Analysis

The liquid form segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)     

Due to an increase in the availability of liquid enteral collagen peptide protein products and a rise in health concerns among consumers, the liquid segment is expected to grow significantly during the forecast period, owing to an increase in demand and consumption of enteral supplements that come in the form of liquid. Most liquid collagens have the advantage of being hydrolyzed. That means its large proteins have already been broken down, saving our bodies a step and making them easier to digest. Since, collagen is a protein found in many different body parts, including the cartilage between bones. Because collagen is composed of amino acids, which are the building blocks of protein, it has been proposed that the body can use the amino acids in collagen supplements to protect and rebuild joint cartilage that has been damaged by osteoarthritis (OA) and rheumatoid arthritis (RA).For instance, one of the most common types of arthritis, osteoarthritis (OA), also known as degenerative joint disease, affects more than 32.5 million adults.

Moreover, in May 2021, Nestlé Health Science & Technology China has opened a flagship store on Tmall for Vital Proteins, its peptide collagen brand from the United States, to educate Chinese consumers that collagen supplements are beneficial not only for skin beauty but also for immune, joint health, and sports performance.All these factors are driving the growth of this segment.

Enteral Collagen Peptide Protein Market

Enteral Collagen Peptide Protein Market Geographical Analysis

Asia-Pacific region holds the largest market share of the global enteral collagen peptide protein market.

Due to an increase in the geriatric population, R&D investments in the development of collagen peptide protein products for various chronic diseases, supportive government initiatives aimed at reducing malnutrition deficiency, and a significant surge in demand for advanced healthcare facilities, Asia-Pacific presents lucrative opportunities for key players operating in the enteral collagen peptide protein market.

Furthermore, an increase in the number of people suffering from arthritis disease, as well as a surge in the focus of leading manufacturers on expanding their geographical presence in emerging Asia-Pacific countries to capture a large market share, are expected to drive growth in the region's enteral collagen peptide protein market.

Enteral Collagen Peptide Protein Market Competitive Landscape

To improve product penetration, the major players in the enteral collagen peptide protein market have been focusing on new marketing and sales techniques. In addition, the growing preference for online distribution channels has played a significant influence. Some of the key players which are contributing to the growth of the market include Abbott Laboratories, Hexagon Nutrition, Dermarites Industries LLC, Designer Wellness, Global Health Products Inc, Fresenius Kabi AG, Gelita AG, Weishardt Holding SA, Kayos, Vital Proteins.

The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the Enteral Collagen Peptide Protein market globally. For instance May 2021, The Western Australian government awarded Holista Colltech a USD 0.5 million grant under the Collie Futures Industry Development Fund to enhance collagen manufacturing. Holista Colltech will increase the production of higher-quality medical-grade collagen due to this initiative.

Key Developments

On June 10,2020 , Nestlé Health Science (NHS), a global leader in nutritional science, has agreed to buy a majority stake in Vital Proteins, America's leading collagen brand and a lifestyle and wellness platform including supplements, beverages, and food products. The deal is subject to regulatory approval.

Dermarites Industries

Overview: DermaRite produces low-cost skin care, wound care, and nutritional supplements for healthcare facilities such as hospitals, nursing homes, hospices, and home care. DermaRite's state-of-the-art manufacturing and warehousing facility is located in North Bergen, New Jersey, founded in 1995. With a distribution and sales network spanning the United States, facilities expect prompt, dependable service and personalized attention. Customers of DermaRite also have access to various clinical and educational tools, making us one of the best values in the industry. DermaRite is a manufacturer that the FDA and OSHA have approved.

Product Portfolio:

ProHeal:  ProHeal is a medical food designed for the dietary management of wounds and conditions that necessitate supplemental protein. ProHeal is a liquid protein supplement that contains a concentrated blend of hydrolyzed collagen and whey protein for maximum protein absorption and content.

Frequently Asked Questions

What is the Projected CAGR value of the Enteral Collagen Peptide Protein Market?

Enteral Collagen Peptide Protein Market is expected to grow at a CAGR of 7% during the forecasting period 2022-2029.

Which region controlled the global market during 2022-2029?

North America region Controls the Enteral Collagen Peptide Protein Market during 2022-2029

Which is the fastest growing region in the Enteral Collagen Peptide Protein Market?

Among all regions, Asia Pacific is the fastest growing market share during the forecast period

Trending Topics

Single Use Assemblies Market

Plantar Fasciitis Treatment Market

Healthcare Analytical Testing Services Market